[HTML][HTML] Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute …
MC Pasquini, S Devine, A Mendizabal… - Journal of clinical …, 2012 - ncbi.nlm.nih.gov
Journal of clinical oncology, 2012•ncbi.nlm.nih.gov
Purpose T-cell depletion (TCD) reduces the incidence of graft-versus-host disease (GVHD)
after hematopoietic cell transplantation (HCT). However, concerns about relapse, graft
rejection, and variability in technique have limited the widespread application of this
approach.
after hematopoietic cell transplantation (HCT). However, concerns about relapse, graft
rejection, and variability in technique have limited the widespread application of this
approach.
Abstract
Purpose
T-cell depletion (TCD) reduces the incidence of graft-versus-host disease (GVHD) after hematopoietic cell transplantation (HCT). However, concerns about relapse, graft rejection, and variability in technique have limited the widespread application of this approach.
ncbi.nlm.nih.gov